L1TD1 and medulloblastoma: In this context, L1TD1 was identified as a possible prognostic marker for medulloblastoma (Santos et al., 2015) and colorectal tumors (Chakroborty et al., 2019), where its expression is highly correlative with malignancy progression (Urh et al., 2021).